Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

36.69
Delayed Data
As of Aug 28
 +0.46 / +1.27%
Today’s Change
11.33
Today|||52-Week Range
37.19
+153.56%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues1.1M27.0K0.000.00
 
 
 
Depreciation And Amortization1.0M1.2M1.3M1.3M
 
 
 
 
 
 
Operating ExpensesGross Income-----1.3M-1.3M
 
 
 
General Expenses33.7M43.6M51.3M40.8M
 
 
 
 
 
Research And Development21.9M30.8M39.2M29.2M
 
 
 
 
 
Total Operating Expenses34.7M44.7M52.6M42.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-33.7M-44.7M-52.6M-42.1M
 
 
 
 
 
Extraordinary Credit4.3M------
 
 
Extraordinary Charge-----9.3M--
 
 
Other Expenses0.00306.0K0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-29.2M-44.4M-61.6M-41.9M
 
 
 
 
 
Net Income-29.2M-44.4M-61.6M-41.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.1M41.3M41.3M41.4M
 
 
 
 
 
Shares To Calculate EPS Diluted41.1M41.3M41.3M41.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.71-$1.08-$1.49-$1.01
 
 
 
 
 
EPS Diluted-$0.71-$1.08-$1.49-$1.01